pH-sensitive Silk Fibroin Nanoparticles Encapsulating β-Hydroxyisovalerylshikonin for Targeted Pancreatic Cancer Therapy
This study successfully developed pH-responsive SF@β-HIVS nanoparticles and validated their potential in treating pancreatic cancer. These findings provided a foundation for the clinical application of SF@β-HIVS in pancreatic cancer treatment.
Authors
- Xiao Hu (ORCID: https://orcid.org/0000-0003-1128-4099)
- Ruiyao Zhou (ORCID: https://orcid.org/0000-0001-8195-4102)
- Haifeng Zhang (ORCID: https://orcid.org/0000-0003-0227-9861)
- Shangdong Wang
- Qiuhui Wang (ORCID: https://orcid.org/0009-0002-2441-9503)
- Jianwu Cai
Institutions
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
Publication Details
- Journal
- Current Drug Delivery
- Published
- 2025-01-09
- DOI
- https://doi.org/10.2174/0115672018342718241030070142
- Primary Topic
- Phytochemical compounds biological activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00